Lipase is an essential enzyme for the decomposition of fat in gastrointestinal tract. This product can be combined with serine residues of gastric and pancreatic lipases to inactivate lipases, so that they cannot decompose fat in food into free fatty acids, and inhibit the utilization and absorption of fat. In addition, this product can also reduce the risk factors related to obesity.
Extended data:
Orlistat, which is used for obese patients with type 2 diabetes, loses weight after treatment with this product, usually accompanied by improvement of blood sugar control. Need to adjust hypoglycemic drugs to avoid hypoglycemia. Pregnant and lactating women,/kloc-children and adolescents under 0/8 years old have not studied the safety and efficacy, so please do not use it.
Patients with chronic malabsorption syndrome or cholestasis and allergic to orlistat or any other ingredients in pharmaceutical preparations are prohibited; Medication must be carried out through a regular hospital under the guidance of a doctor.
Baidu Encyclopedia-Orlister